logo

Hepion Pharmaceuticals, Inc. (HEPA)



Trade HEPA now with
  Date
  Headline
5/31/2019 8:03:39 AM ContraVir Announces Reverse Split Of Its Common Stock
4/25/2019 9:05:20 AM ContraVir Reports Pricing Of $2.14 Mln Public Offering
10/30/2018 8:06:49 AM Leading BioSciences Appoints James Neal And James Sapirstein To Board
10/30/2018 8:05:46 AM ContraVir Pharma Completes Final Cohort Dosing In CRV431 Drug-Drug Interaction Study
10/3/2018 8:04:41 AM ContraVir Pharma Appoints Robert Foster As Acting CEO
9/18/2018 9:07:34 AM ContraVir Says Primary Endpoints Of Safety And Tolerability Met In Single Ascending Dose Study Of CRV431
6/29/2018 8:04:35 AM ContraVir Announces $10.8 Mln In Expected Gross Proceeds From Recently Expired Rights Offering
6/25/2018 8:13:51 AM ContraVir Pharma Initiates Dosing Of CRV431 In First In-Human Trial
6/20/2018 12:31:58 PM ContraVir Pharmaceuticals Regains Compliance With Nasdaq Listing Requirements